Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's HCA Healthcare, Inc. (HCA) position

Yes: as of Q1 2026, Ken Griffin holds 259K shares of HCA worth $122M (0.1% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$122M
Shares held
259K
% of portfolio
0.1%
Est. average buy price (i)
$446.95
Quarter-end price
$473.24

Estimated trade prices

Average price in quarters with purchases
$256.03
Average prices in quarters with sales
  • Q1 2026: $503.56 (83K shares sold)
  • Q3 2024: $366.12 (15K shares sold)
  • Q2 2024: $324.92 (115K shares sold)
  • Q4 2023: $247.16 (381K shares sold)
  • Q2 2023: $278.02 (283K shares sold)
  • Q1 2023: $254.01 (437K shares sold)
  • Q4 2022: $223.97 (357K shares sold)
  • Q1 2022: $251.12 (143K shares sold)
  • Q4 2021: $244.70 (427K shares sold)

HCA price vs Griffin's position

1Y 3Y 5Y MAX
Dates
$350$400$450$500$5502026New position of 78K shares · Q3 2025. Average closing price $387.58 · Price range $334.32–$426.5478KsharespurchasedAdded 264K shares (338.8%) · Q4 2025. Average closing price $464.47 · Price range $410.68–$515.85264KsharespurchasedSold 83K shares (24.2%) · Q1 2026. Average closing price $503.56 · Price range $464.38–$545.1383Ksharessold← Earlier —6 purchases, 8 sells
Average closing price · filing quarter
$503.56
Price range · filing quarter
$464.38 – $545.13
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −83K −$42M −24.2% 259K May 15, 2026
Q4 2025 Added +264K +$122M +338.8% 341K Feb 17, 2026
Q3 2025 New +78K +$30M – 78K Nov 14, 2025
Q4 2024 Added +122K +$43M +346.4% 157K Feb 14, 2025
Q3 2024 Reduced −15K −$5.7M −30.6% 35K Nov 14, 2024
Q2 2024 Reduced −115K −$38M −69.5% 51K Aug 14, 2024
Q1 2024 Added +76K +$23M +85.3% 166K May 15, 2024
Q4 2023 Reduced −381K −$94M −81.0% 90K Feb 14, 2024
Q3 2023 Added +61K +$17M +14.9% 471K Nov 14, 2023
Q2 2023 Reduced −283K −$79M −40.9% 409K Aug 14, 2023
Q1 2023 Reduced −437K −$111M −38.7% 693K May 15, 2023
Q4 2022 Reduced −357K −$80M −24.0% 1.1M Feb 14, 2023
Q3 2022 Added +1.1M +$229M +337.3% 1.5M Nov 14, 2022
Q2 2022 Added +193K +$42M +131.7% 340K Aug 15, 2022
Q1 2022 Reduced −143K −$36M −49.3% 147K May 16, 2022
Q4 2021 Reduced −427K −$105M −59.6% 290K Feb 14, 2022
Q3 2021 New +717K +$175M – 717K Nov 15, 2021
Q1 2021 First covered – – – 203K May 21, 2021
Data through Q1 2026 · filed May 15, 2026
18 grouped rows from 18 quarters

More Griffin positions

NVIDIA Corporation(NVDA)
$3.2B
2.3% of portfolio

Amazon.com, Inc.(AMZN)
$1.7B
1.2% of portfolio

Micron Technology, Inc.(MU)
$1.6B
1.1% of portfolio

Taiwan Semiconductor Manufacturing Company Limited(TSM)
$1.4B
1.0% of portfolio

Apple Inc.(AAPL)
$1.3B
0.9% of portfolio

Meta Platforms, Inc.(META)
$1.0B
0.7% of portfolio

Common questions

Does Ken Griffin own HCA?

Yes. As of Q1 2026, Ken Griffin disclosed 259K shares of HCA, worth $122M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy HCA?

Ken Griffin held HCA since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell HCA?

The quarter-by-quarter table above shows each sale and reduction Ken Griffin disclosed in HCA. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of HCA does Ken Griffin own?

Ken Griffin disclosed 259K shares of HCA as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for HCA?

Ken Griffin's estimated average buy price for HCA is $446.95, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.